Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-K Annual Report
Period Ended: December 31, 2001
Business Overview: The Company is a nationwide provider of temporary scientific and healthcare professionals. It operates through two segments: Lab Support (scientific professionals for biotech, pharma, and chemical industries) and Healthcare Staffing (medical billing, clinical lab, and diagnostic imaging staff). As of December 31, 2001, the Company operated 171 branch offices across 81 markets in the U.S., Canada, and Europe.
Key Financial Metrics (Year Ended Dec 31, 2001)
| Metric | 2001 (in thousands) | 2000 (in thousands) |
|---|---|---|
| Revenues | $194,620 | $195,080 |
| Cost of Services | $131,343 | $131,351 |
| Gross Profit | $63,277 | $63,729 |
| Gross Margin | 32.5% | 32.7% |
| Operating Income | $24,511 | $28,197 |
| Net Income | $17,040 | $19,247 |
| Diluted EPS | $0.74 | $0.83 |
| Cash & Cash Equivalents | $65,694 | $51,202 |
| Working Capital | $105,851 | $84,717 |
| Long-Term Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 0.2% to $194.6 million. This was driven by a 4.6% decrease in the number of temporary employees on assignment in the Lab Support segment and a 5.1% decrease in the Healthcare Staffing segment, attributed to an economic slowdown beginning in February 2001. These volume declines were partially offset by increases in average hourly billing rates (4.8% for Lab Support, 5.8% for Healthcare Staffing).
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 9.1% to $38.8 million (19.9% of revenue vs. 18.2% in 2000). This increase was primarily due to investments in Account Manager training, recruiting, and the hiring of new managers.
- Profitability: Operating income decreased 13.1% to $24.5 million, and Net Income decreased 11.5% to $17.0 million.
- Liquidity: Cash and cash equivalents increased by $14.5 million to $65.7 million. The Company generated $25.5 million in cash from operating activities.
Guidance, Outlook, Risks, and Unusual Items
- Major Acquisition (Subsequent Event): On March 27, 2002, the Company entered into a Merger Agreement to acquire Health Personnel Options Corporation (HPO) for approximately $150 million (50% cash, 50% stock). The transaction was scheduled to close in April 2002. HPO specializes in travel nurses and allied healthcare staff.
- Stock Repurchases: The Company repurchased 473,500 shares of common stock in 2001. As of year-end, it had authorization to repurchase an additional 1.8 million shares.
- Management Changes: Joseph Peterson, M.D., became CEO and President effective September 1, 2001, succeeding H. Tom Buelter, who retired as CEO and later resigned as Chairman in February 2002.
- Key Risks:
- Seasonality: Demand typically declines during the year-end holiday season through February and during summer months (June-August).
- Account Manager Dependency: Success relies heavily on the ability to recruit, train, and retain qualified Account Managers.
- Workers' Compensation: The Company is partially self-insured; fluctuations in claims or insurance premiums could materially impact profitability.
- Integration Risk: The pending HPO acquisition poses integration challenges and potential dilution from the issuance of approximately 3.9 million new shares.
Investor Verification Checklist
- Acquisition Closing: Verify the successful closing of the HPO merger and the final purchase price adjustments.
- Integration Progress: Monitor the integration of HPO's operations and the realization of anticipated synergies.
- Seasonal Trends: Review Q1 2002 results to confirm the severity of the typical seasonal demand decline.
- Workers' Compensation Reserves: Assess the adequacy of the $2.66 million accrued liability for workers' compensation claims.
- Stock Dilution: Evaluate the impact of the ~17% increase in outstanding shares resulting from the HPO stock consideration on future EPS.